Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Pathways and targets of Gusuibu in the treatment of osteoporosis based on systematic pharmacology
Hits 1510  Download times 1011  Received:May 20, 2019  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2019.11.24
Key Words   Gusuibu;osteoporosis;systemic pharmacology;pathway;target;mechanism
Author NameAffiliationE-mail
ZHAO Jinlong Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guagnzhou 510405, China
Guangdong Academy of Traditional Chinese Medicine, Research Team on Bone and Joint Degeneration and Injury, Guangzhou 510120, China 
 
ZENG Lingfeng Guangdong Academy of Traditional Chinese Medicine, Research Team on Bone and Joint Degeneration and Injury, Guangzhou 510120, China
Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510120, China 
 
ZHAO Di Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guagnzhou 510405, China
Guangdong Academy of Traditional Chinese Medicine, Research Team on Bone and Joint Degeneration and Injury, Guangzhou 510120, China 
 
PAN Jianke Guangdong Academy of Traditional Chinese Medicine, Research Team on Bone and Joint Degeneration and Injury, Guangzhou 510120, China
Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510120, China 
 
HAN Yanhong Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guagnzhou 510405, China
Guangdong Academy of Traditional Chinese Medicine, Research Team on Bone and Joint Degeneration and Injury, Guangzhou 510120, China 
 
LIANG Guihong Guangdong Academy of Traditional Chinese Medicine, Research Team on Bone and Joint Degeneration and Injury, Guangzhou 510120, China
Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510120, China 
 
LI Jiahui Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guagnzhou 510405, China
Guangdong Academy of Traditional Chinese Medicine, Research Team on Bone and Joint Degeneration and Injury, Guangzhou 510120, China 
 
LIU Jun Guangdong Academy of Traditional Chinese Medicine, Research Team on Bone and Joint Degeneration and Injury, Guangzhou 510120, China
Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510120, China 
liujun.gdtcm@hotmail.com 
Abstract
    [Objective] To explore the biological pathway and target of gusuibu in the treatment of osteoporosis by systematic pharmacology-related bioinformatics analysis.[Methods] The active constituents and target proteins of Gusuibu were extracted from TCMSP database. By using Cytoscape 3.5.1 to construct the relationship network between effective components and target of gusuibu for topological analysis. STRING10.5 database was used to construct and analyze protein-protein interaction (PPI) network. KEGG pathway function enrichment analysis was carried out with the help of David database.[Results] Naringin,eriodic tyol and kaempferol were the core compounds of Gusuibu. Prostaglandin G/H synthase 2,Heat shock protein HSP 90 and Caspase-3 were the important targets. JUN,TP53,MAPK1,IL-6,ESR1 were the key proteins in the effective components of gusuibu. KEGG results showed that osteoporosis mainly acted on TNF signaling pathway,T cell receptor signaling pathway,HIF-1 signaling pathway,PI3K-Akt signaling pathway,estrogen signaling pathway and other related signaling pathways.[Conclusion] Gusuibu has the biological effect of anti-osteoporosis through a variety of pathways and signaling pathways acting on a variety of targets.

You are the 2319595 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.